Zantac was one of some seven anti-acid remedies available - until April 1, 2020 [1], when the FDA asked for its voluntary recall.It wasn’t that the drug, known as ranitidine, per se, was a ...

KEY TAKEAWAYS. The Zantac recall created an opportunity for legal action by patients who had been taking the drug, and the first court case is set to begin in February 2023 in California.

Sanofi is among several companies facing lawsuits that claim Zantac—which was developed by GSK and approved in 1983—can cause cancer. Sanofi acquired the then-over-the-counter treatment in a ...

Sanofi discontinued the ranitidine formulation of Zantac, and the new formulation, Zantac 360, is made with a different active ingredient.

79,000. That’s how many cases related to Zantac GSK still face, according to Reuters. The majority of these, some 73,000, are in Delaware, ...

The press typically treats lawsuits against business as inherently righteous and amplifies the junk science behind them. So in case you missed it, a federal judge on Tuesday dismissed claims that ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Popular heartburn drug Ranitidine, long under scrutiny, will continue to be available in India as the government confirmed it had no plans to ban its manufacture or sale. The government had ...

That said, this bulletin is not a notice of yet another impending recall, as the FDA notes that it’s still determining how big of a risk this particular discovery poses to the public.

Safe alternatives to Zantac are available. The drug is one of several H2-receptor antagonists (H2RAs), including cimetidine (Tagamet) and famotidine (Pepcid).

Ideally Ranitidine can produce other side effects as well in some people like diarrhea, headache, nausea, indigestion, abdominal pain, auto immune hemolytic anemia.